4Olesen J. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalagia, 1988,8(suppl): 71 ～ 96.
5Ohta A, Arai Y, Takitani S. Fluorometric determination of nitrite. Anal Chem, 1986, 58: 3132.
6Stepien A, Chalimoniuk M. Level of nitric oxide-dependent cGMP inpatients with migrains. Cephalalgia,1998,18:631～634.
7Johnson KW, Phebus LA, Cohen ML. Serotinin in migraine: theories, animal models and emerging therapies. Prog Drug Res, 1998, 51:219 ～ 244.
8Goadsby PJ, Edvisson L, Ekman R. Vasoactive peptides in migraine attacks. Ann Neurol, 1990,4:294 ～ 301.
9Lassen LH, Ashina M, Christiansen I, et al. Nitric oxide synthase inhibition: a new principle in the treatment of migrain attacks. Cephalalgia, 1998,18: 27 ～32.
10Manfred Zimmermann.Chronic pain--New concepts for therapy and prevention.Chinese Journal of Pain Medicine,2000,6(Suppl 15):2.
